China Universal Asset Management Co., Ltd. Harrow Health, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,552 shares of HROW stock, worth $206,018. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,552
Previous 6,825
10.65%
Holding current value
$206,018
Previous $306,000
17.32%
% of portfolio
0.02%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$109 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$58.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$51.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$46.2 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$24.7 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $738M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...